IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $748,000 | +131.6% | 28,760 | +313.8% | 0.11% | +68.2% |
Q4 2020 | $323,000 | -50.5% | 6,951 | -64.9% | 0.07% | -60.2% |
Q3 2020 | $652,000 | +207.5% | 19,821 | +156.1% | 0.17% | +133.8% |
Q2 2020 | $212,000 | -37.3% | 7,740 | -31.4% | 0.07% | -50.0% |
Q1 2020 | $338,000 | – | 11,285 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |